Chrisy Ngilneii's Profile

B.Sc (Psychology), M.A (Sociology), Ph.D. (Epidemiology)

Chrisy Ngilneii

Chrisy is a Ph.D. Research Scholar at the University of Madras. Her area of specialization is in Epidemiology of Cancer. Writing is her passion. She has published scholarly articles on health topics in prominent journals, and had also edited two books in the academic field which are now available on view more..

Written / Edited / Medically Reviewed

Amazonian Drug Associated With a Sense of Well-Being

Amazonian Drug Associated With a Sense of Well-Being

Traditional Amazonian drug has been linked to an improved sense of wellbeing and lesser problematic alcohol use compared to other psychedelic drugs.

Health Watch
Immunotherapy Appears Safe for Cancer Patients With HIV

Immunotherapy Appears Safe for Cancer Patients With HIV

For cancer patients with HIV, immunotherapy appears safe. Immunotherapies called checkpoint inhibitors are highly effective against different cancers.

Health Watch
 Anti-inflammatory Molecules May be Used To Treat Glaucoma

Anti-inflammatory Molecules May be Used To Treat Glaucoma

Lipoxins, anti-inflammatory molecules secreted from astrocytes may provide new treatment for glaucoma by stopping the degeneration of retinal ganglion cells.

Health Watch
Chloroquine to Improve Drug Delivery to Tumors

Chloroquine to Improve Drug Delivery to Tumors

Chloroquine, an age-old malaria treatment has been found to improve nanoparticle delivery to tumors. Chloroquine can act as a macrophage-preconditioning agent.

Health Watch
 Sertraline Not Effective for Chronic Kidney Disease Patients

Sertraline Not Effective for Chronic Kidney Disease Patients

Standard anti-depressant sertraline may not be effective for major depressive disorder in patients with non–dialysis-dependent chronic kidney disease.

Health Watch